Comments
Acadia redesigns study on Parkinson's psychosis drug
14.07.2012. | (Reuters) - Acadia Pharmaceuticals Inc said it redesigned an ongoing late-stage study on its experimental anti-psychotic drug for Parkinson's disease patients, and that it plans to conduct an identical study to win regulatory approval....
